Michel Feraud founded Provepharm with Christophe Baralotto about thirty years ago, right after their chemistry doctorates.
They started with 51,000 francs, lab benches rented from the university and contract work for large groups.
Today, the group based in Château-Gombert has 75 employees and is developing a unique platform of surgical dyes for precision surgery.
In this episode, he tells the turning point that changed everything: when offshoring to Asia made revenue collapse, he suggested to his partner that they go all in on methylene blue, a 150-year-old molecule everyone laughed at.
A patent, Europe, then the United States.
We talk about unlearning, the line between error and negligence, a leader’s decision (“it’s not the boss who is right, it’s the boss who decides”), the roped party in the Himalayas, the Olympic swimmer who will never win a medal, and AI: a help, not a substitute.

